4-56656000-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_139211.5(HOPX):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000188 in 1,597,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 34)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
HOPX
NM_139211.5 start_lost
NM_139211.5 start_lost
Scores
1
5
10
Clinical Significance
Conservation
PhyloP100: 2.96
Genes affected
HOPX (HGNC:24961): (HOP homeobox) The protein encoded by this gene is a homeodomain protein that lacks certain conserved residues required for DNA binding. It was reported that choriocarcinoma cell lines and tissues failed to express this gene, which suggested the possible involvement of this gene in malignant conversion of placental trophoblasts. Studies in mice suggest that this protein may interact with serum response factor (SRF) and modulate SRF-dependent cardiac-specific gene expression and cardiac development. Multiple alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOPX | NM_032495.6 | c.55A>G | p.Met19Val | missense_variant | 3/4 | ENST00000420433.6 | NP_115884.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOPX | ENST00000420433.6 | c.55A>G | p.Met19Val | missense_variant | 3/4 | 5 | NM_032495.6 | ENSP00000396275.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151448Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
1
AN:
151448
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1445590Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 718564
GnomAD4 exome
AF:
AC:
2
AN:
1445590
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
718564
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151448Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 73976
GnomAD4 genome
AF:
AC:
1
AN:
151448
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
73976
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.55A>G (p.M19V) alteration is located in exon 3 (coding exon 2) of the HOPX gene. This alteration results from a A to G substitution at nucleotide position 55, causing the methionine (M) at amino acid position 19 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.;T;T;T;T;T;T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;.;.;.;.;.;.;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
Sift
Benign
T;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Benign
T;D;T;D;D;D;D;D;D;D;D;D
Polyphen
0.28
.;B;.;B;B;B;B;B;B;B;.;B
Vest4
MutPred
1.0
.;Gain of glycosylation at S2 (P = 0.0914);.;Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);Gain of glycosylation at S2 (P = 0.0914);
MVP
MPC
0.32
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at